'Paradigm Shift': Luspatercept for MDS
Luspatercept showed significant improvement over erythropoiesis-stimulating agent epoetin alfa in reducing dependency on red blood cell transfusions in patients with LR-MDS who are ESA naive.
Stay updated with breaking news from Chronic Anemia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Luspatercept showed significant improvement over erythropoiesis-stimulating agent epoetin alfa in reducing dependency on red blood cell transfusions in patients with LR-MDS who are ESA naive.
Thalassemia patients receive support from DKMS-BMST, which has been at the forefront of organizing support for them by assisting in finding compatible donors.
email article A 61-year-old woman presents to a hospital in Austria for an outpatient gastroscopy due to an ongoing problem with black and tarry stools. She has no abdominal pain or problems with elimination. Her only comorbidity is psoriasis vulgaris, and she is a non-smoker. Her medical history includes having had an open appendectomy, and she reports having suffered a stroke about 20 years previously, for which she took aspirin until about 11 years ago, although there are no medical records to verify the diagnosis. The patient underwent two previous gastroscopies (the first at age 21...